Matches in Wikidata for { <http://www.wikidata.org/entity/Q66070141> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q66070141 description "clinical trial" @default.
- Q66070141 description "ensayu clínicu" @default.
- Q66070141 description "klinisch onderzoek" @default.
- Q66070141 description "клінічне випробування" @default.
- Q66070141 description "կլինիկական փորձարկում" @default.
- Q66070141 name "The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions" @default.
- Q66070141 name "The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions" @default.
- Q66070141 type Item @default.
- Q66070141 label "The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions" @default.
- Q66070141 label "The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions" @default.
- Q66070141 prefLabel "The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions" @default.
- Q66070141 prefLabel "The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions" @default.
- Q66070141 P1132 Q66070141-E198BC0A-7AFA-4837-A514-EB052A087913 @default.
- Q66070141 P1476 Q66070141-03312C52-521C-4A38-8E76-0E580AC45818 @default.
- Q66070141 P17 Q66070141-C6257942-5FCB-4407-899F-A6B1DD7366FC @default.
- Q66070141 P2899 Q66070141-E0645B4E-F933-4797-B4EE-632D25F5D547 @default.
- Q66070141 P3098 Q66070141-B845AFA5-DB28-4C10-B0C9-2A69B01D8CEF @default.
- Q66070141 P31 Q66070141-A1DF5877-53FD-497B-A6B3-E1B40C5F2086 @default.
- Q66070141 P4135 Q66070141-790CA97A-D3E8-40A3-9702-731B45191AC3 @default.
- Q66070141 P4844 Q66070141-87ABFC61-B5A2-4974-A830-4A4FED3FDFF2 @default.
- Q66070141 P580 Q66070141-03976F4E-81EB-489C-BFD6-29C47515D75D @default.
- Q66070141 P582 Q66070141-3FD904D9-CCB8-4415-85D4-F5731C254C85 @default.
- Q66070141 P6099 Q66070141-F545885F-733F-4FC0-83D0-BEBC1A799168 @default.
- Q66070141 P8363 Q66070141-67F5FEAF-56E6-4DDF-B1C8-5334602535BF @default.
- Q66070141 P1132 "+284" @default.
- Q66070141 P1476 "A Two Part Bioequivalence Study to Compare Two Fixed Dose Combination (FDC) Tablets of Dapagliflozin/Metformin XR 5/500 mg (Part 1) and 10/1000 mg (Part 2) Manufactured at Two Different Plants (Humacao, Puerto Rico and Mount Vernon, US) in Healthy Subjects Under Fasting and Fed Conditions" @default.
- Q66070141 P17 Q155 @default.
- Q66070141 P2899 "+18" @default.
- Q66070141 P3098 "NCT03216278" @default.
- Q66070141 P31 Q30612 @default.
- Q66070141 P4135 "+50" @default.
- Q66070141 P4844 Q19484 @default.
- Q66070141 P580 "2017-09-26T00:00:00Z" @default.
- Q66070141 P582 "2018-05-22T00:00:00Z" @default.
- Q66070141 P6099 Q5452194 @default.
- Q66070141 P8363 Q78089383 @default.